DrugPatentWatch Database Preview
Pertuzumab - Biologic Drug Details
Try a free trial
See Plans and Pricing
Summary for pertuzumab
| Tradenames: | 1 |
| Patents: | 168 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for pertuzumab |
Pharmacology for pertuzumab
| Mechanism of Action | HER2/Neu/cerbB2 Antagonists |
US Patents for pertuzumab
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | Try a Free Trial | Array BioPharma Inc. (Boulder, CO) | 2029-10-21 | RX | search | |
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | Try a Free Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | search | |
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | Try a Free Trial | Pharmacyclics LLC (Sunnyvale, CA) | 2033-08-12 | RX | search | |
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | Try a Free Trial | University of Georgia Research Foundation, Inc. (Athens, GA) | 2038-10-10 | RX | search | |
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | Try a Free Trial | MEDIMMUNE, LLC (Gaithersburg, MD) | 2031-11-23 | RX | search | |
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | Try a Free Trial | Celcuity LLC (Minneapolis, MN) | 2032-06-12 | RX | search | |
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | Try a Free Trial | AbbVie Stemcentrx LLC (North Chicago, IL) | 2033-02-08 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for pertuzumab
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Taiwan | I501976 | Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 2015195925 | Try a Free Trial |
| Portugal | 2049501 | Try a Free Trial |
| Australia | 2003234624 | Try a Free Trial |
| Eurasian Patent Organization | 201692560 | Try a Free Trial |
| Taiwan | 201442725 | Try a Free Trial |
| Hong Kong | 1112588 | Try a Free Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for pertuzumab
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2 50002-2015 | Slovakia | Try a Free Trial | PRODUCT NAME: POMALIDOMID; REGISTRATION NO/DATE: EU/1/13/850/001 - EU/1/13/850/004 20130808 |
| 140 | Estonia | Try a Free Trial | |
| 2015000013 | Germany | Try a Free Trial | PRODUCT NAME: POMALIDOMID UND SEINE PHARMAZEUTISCH AKZEPTABLEN SALZE, SOLVATE, HYDRATE ODER STEREOISOMERE (IMNOVID); REGISTRATION NO/DATE: EU/1/13/850 20130805 |
| 0150005 00140 | Estonia | Try a Free Trial | PRODUCT NAME: POMALIDOMIID;REG NO/DATE: EU/1/13/850 08.08.2013 |
| 2015 00006 | Denmark | Try a Free Trial | PRODUCT NAME: POMALIDOMID OG FARMACEUTISK ACCEPTABLE SALTE, SOLVATER, HYDRATER ELLER STEREOISOMERER HERAF; REG. NO/DATE: EU/1/13/850 20130805 |
| 0717 | Netherlands | Try a Free Trial | PRODUCT NAME: POMALIDOMIDE EN FARMACEUTISCH AANVAARDBARE ZOUTEN, SOLVATEN, HYDRATEN OF STEREOISOMEREN DAARVAN; REGISTRATION NO/DATE: EU/1/13/850 20130805 |
| 90004-6 | Sweden | Try a Free Trial | PRODUCT NAME: POMALIDOMIDE AND PHARMACEUTICALLY ACCEPTABLE SALTS, SOLVATES, HYDRATES OR STEREOISOMERS THEREOF; REG. NO/DATE: EU/1/13/850 20130808 |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
